Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Itou

Showing results (831-840 of 866) with videos related to

Pageof 87
Sort By:
Journal of Medicinal Chemistry|March 1, 2008
Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human beta3-adrenergic receptor agonists with good oral bioavailability. Part IMasashi Imanishi, Yasuyo Tomishima, Shinji Itou, et al.
Oncotarget|October 18, 2019
Clinical significance of evaluating hormone receptor and HER2 protein using cell block against metastatic breast cancer: a multi-institutional studyAkira Matsui, Yuya Murata, Norikazu Masuda, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2018
BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II-DNA complexesHiroyuki Sasanuma, Masataka Tsuda, Suguru Morimoto, et al.
Journal of Medicinal Chemistry|May 22, 2012
Discovery of highly potent human deoxyuridine triphosphatase inhibitors based on the conformation restriction strategySeiji Miyahara, Hitoshi Miyakoshi, Tatsushi Yokogawa, et al.
Journal of Medicinal Chemistry|June 22, 2012
1,2,3-Triazole-containing uracil derivatives with excellent pharmacokinetics as a novel class of potent human deoxyuridine triphosphatase inhibitorsHitoshi Miyakoshi, Seiji Miyahara, Tatsushi Yokogawa, et al.
Journal of Medicinal Chemistry|February 21, 2012
Discovery of a novel class of potent human deoxyuridine triphosphatase inhibitors remarkably enhancing the antitumor activity of thymidylate synthase inhibitorsSeiji Miyahara, Hitoshi Miyakoshi, Tatsushi Yokogawa, et al.
Journal of Medicinal Chemistry|June 17, 2008
Discovery of a novel series of biphenyl benzoic acid derivatives as highly potent and selective human beta3 adrenergic receptor agonists with good oral bioavailability. Part IIMasashi Imanishi, Shinji Itou, Kenichi Washizuka, et al.
Bone Marrow Transplantation|August 28, 2003
Influence of transplanted dose of CD56+ cells on development of graft-versus-host disease in patients receiving G-CSF-mobilized peripheral blood progenitor cells from HLA-identical sibling donorsS Yamasaki, H Henzan, Y Ohno, et al.
Journal of Cardiology|December 29, 2018
Different determinants of vascular and nonvascular deaths in patients with atrial fibrillation: A SAKURA AF Registry substudyKeiichiro Kuronuma, Yasuo Okumura, Katsuaki Yokoyama, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2009
Discovery of highly potent and selective biphenylacylsulfonamide-based beta3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the beta2-adrenergic receptor: part 6Kouji Hattori, Masaya Orita, Susumu Toda, et al.
Pageof 87

Showing results (831-840 of 866) with videos related to

Sort By:
Pageof 87
Journal of Medicinal Chemistry|March 1, 2008
Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human beta3-adrenergic receptor agonists with good oral bioavailability. Part IMasashi Imanishi, Yasuyo Tomishima, Shinji Itou, et al.
Oncotarget|October 18, 2019
Clinical significance of evaluating hormone receptor and HER2 protein using cell block against metastatic breast cancer: a multi-institutional studyAkira Matsui, Yuya Murata, Norikazu Masuda, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2018
BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II-DNA complexesHiroyuki Sasanuma, Masataka Tsuda, Suguru Morimoto, et al.
Journal of Medicinal Chemistry|May 22, 2012
Discovery of highly potent human deoxyuridine triphosphatase inhibitors based on the conformation restriction strategySeiji Miyahara, Hitoshi Miyakoshi, Tatsushi Yokogawa, et al.
Journal of Medicinal Chemistry|June 22, 2012
1,2,3-Triazole-containing uracil derivatives with excellent pharmacokinetics as a novel class of potent human deoxyuridine triphosphatase inhibitorsHitoshi Miyakoshi, Seiji Miyahara, Tatsushi Yokogawa, et al.
Journal of Medicinal Chemistry|February 21, 2012
Discovery of a novel class of potent human deoxyuridine triphosphatase inhibitors remarkably enhancing the antitumor activity of thymidylate synthase inhibitorsSeiji Miyahara, Hitoshi Miyakoshi, Tatsushi Yokogawa, et al.
Journal of Medicinal Chemistry|June 17, 2008
Discovery of a novel series of biphenyl benzoic acid derivatives as highly potent and selective human beta3 adrenergic receptor agonists with good oral bioavailability. Part IIMasashi Imanishi, Shinji Itou, Kenichi Washizuka, et al.
Bone Marrow Transplantation|August 28, 2003
Influence of transplanted dose of CD56+ cells on development of graft-versus-host disease in patients receiving G-CSF-mobilized peripheral blood progenitor cells from HLA-identical sibling donorsS Yamasaki, H Henzan, Y Ohno, et al.
Journal of Cardiology|December 29, 2018
Different determinants of vascular and nonvascular deaths in patients with atrial fibrillation: A SAKURA AF Registry substudyKeiichiro Kuronuma, Yasuo Okumura, Katsuaki Yokoyama, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2009
Discovery of highly potent and selective biphenylacylsulfonamide-based beta3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the beta2-adrenergic receptor: part 6Kouji Hattori, Masaya Orita, Susumu Toda, et al.
Pageof 87